At the Medicap Pharmacy® stores, we are dedicated to providing products and services to care for your family’s wellness. One of those services is health news you can trust. Use the filters to focus on the information that is important to you, then bookmark this page to make it a regular stop anytime you’re online.
Breast Cancer Rx Now Approved for Men
A breast cancer medication that was previously approved for women can now be used to treat men with advanced breast cancer.
Company Under Fire for Illegal Screening Tool
Total Thermal Imaging, Inc., is in the hot seat for marketing and selling an unapproved product for detecting certain diseases.
A New Biosimilar for a Breast Cancer Rx
The US Food and Drug Administration (FDA) has approved the third Herceptin (trastuzumab) biosimilar to treat certain types of cancer.
Mammograms: What You Need to Know
Mammograms can help detect breast cancer at an early stage. That means they can lead to early treatment, which can save lives.
Detecting Breast Cancer Early
Performing regular breast self-exams can make all the difference in women's health.
BRCA Mutations: Who Should Get Tested?
BRCA1 and BRCA2 gene mutations increase breast cancer risk. So how do you know if you have these gene mutations?
Several New Medications Approved
As a new year begins, we celebrate the beginning of something new and exciting. This year, that includes several new medication approvals from the US Food and Drug Administration (FDA).
More Exercise, Less Disease
Many past studies have shown that physical activity provides health benefits, but exactly how much physical activity provides the most benefit?
Cancer Screening: It Could Be Hard to Get the Facts
Most people would agree that cancer screening is a good thing. After all, you're either preventing cancer or catching it early. Unfortunately, the majority of cancer screening guidelines may be lacking in important patient information.
Standard Medication for HER-2 Breast Cancer Remained Top Rx
The approval of a new medication represents new options for patients. But the new option isn't always the best option. When it comes to treating HER-2 positive breast cancer, the standard medication still appears to beat the newer option.